<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font6" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font7" size="9" family="GillSans,Italic" color="#000000"/>
<text top="41" left="55" width="171" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title">Journal of Autoimmune Diseases 2005, 2 :5<i>Journal of Autoimmune Diseases</i></text>
<text top="41" left="395" width="159" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="1" tag_type="text">http://www.jautoimdis.com/content/2/1/5</text>
<text top="756" left="508" width="46" height="10" font="font1" id="p1_t3" reading_order_no="104" segment_no="19" tag_type="text">Page 2 of 5<b>2</b></text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t4" reading_order_no="105" segment_no="20" tag_type="text">(page number not for citation purposes)</text>
<text top="87" left="55" width="241" height="9" font="font4" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="text">had antibodies to nuclear envelope antigens [4] while</text>
<text top="98" left="55" width="241" height="9" font="font4" id="p1_t6" reading_order_no="3" segment_no="2" tag_type="text">another study found the same ANA antibody rates in both</text>
<text top="110" left="55" width="241" height="9" font="font4" id="p1_t7" reading_order_no="4" segment_no="2" tag_type="text">CFS and controls [5]. Recently, investigators reported that<i>(page number not for citation purposes)</i></text>
<text top="122" left="55" width="241" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="2" tag_type="text">antibodies to the human muscarinic cholinergic receptor<a href="">ns [4] while</a></text>
<text top="134" left="55" width="241" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="2" tag_type="text">1 may provide a biologic explanation for the cognitive</text>
<text top="145" left="55" width="241" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="2" tag_type="text">impairment observed in people with CFS [6]. This lack of<a href="">rols [5]. Rece</a>ntly, investigators reported that</text>
<text top="157" left="55" width="241" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="2" tag_type="text">consensus between studies may in large-part reflect</text>
<text top="169" left="55" width="241" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="2" tag_type="text">recruitment bias associated with studies of persons</text>
<text top="181" left="55" width="241" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="2" tag_type="text">enrolled from tertiary referral clinics combined with<a href=""> CFS [6]. T</a>his lack of</text>
<text top="192" left="55" width="241" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="2" tag_type="text">imprecise evaluation of the illness and inadequate or</text>
<text top="204" left="55" width="147" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="2" tag_type="text">inappropriate control populations.</text>
<text top="228" left="55" width="241" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="6" tag_type="text">We had the opportunity to measure the associations of</text>
<text top="239" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="6" tag_type="text">common autoantibodies and autoantibodies to neuronal</text>
<text top="251" left="55" width="241" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="6" tag_type="text">cell antigens and CFS in two case control studies; one of</text>
<text top="263" left="55" width="241" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="6" tag_type="text">primary care patients with CFS who were identified by a</text>
<text top="275" left="55" width="241" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="6" tag_type="text">physician surveillance network; the other a study of peo-</text>
<text top="286" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="18" segment_no="6" tag_type="text">ple with CFS identified from the community. The physi-</text>
<text top="298" left="55" width="241" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="6" tag_type="text">cian surveillance study was conducted 1988 through 1993</text>
<text top="310" left="55" width="241" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="6" tag_type="text">in Atlanta, Georgia [7] and the community study 1997</text>
<text top="322" left="55" width="241" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="6" tag_type="text">through 2000 and identified subjects with CFS from the</text>
<text top="333" left="55" width="178" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="6" tag_type="text">general population of Wichita, Kansas [8].</text>
<text top="357" left="55" width="241" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="9" tag_type="text">Both studies rigorously classified people as CFS and con-<a href="">lanta, Georgia [7] and the commun</a>ity study 1997</text>
<text top="369" left="55" width="241" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="9" tag_type="text">trols in both studies were enrolled to represent the general</text>
<text top="380" left="55" width="241" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="9" tag_type="text">population and matched to cases by sex, race, and age<a href="">nsas [8].</a></text>
<text top="392" left="55" width="241" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="9" tag_type="text">[9,10]. The hypothesis of the present study is that the</text>
<text top="404" left="55" width="241" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="9" tag_type="text">appearance of cell-specific autoimmune antibodies may</text>
<text top="416" left="55" width="241" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="9" tag_type="text">define subsets of CFS and give clues to the etiology and</text>
<text top="427" left="55" width="241" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="9" tag_type="text">pathogenesis and may help to explain the neurocognitive<a href="">9,10]. Th</a>e hypothesis of the present study is that the</text>
<text top="439" left="55" width="241" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="9" tag_type="text">symptoms experienced by CFS patients. Secondarily, we</text>
<text top="451" left="55" width="241" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="9" tag_type="text">wished to evaluate the extent to which patients with CFS</text>
<text top="463" left="55" width="241" height="9" font="font4" id="p1_t35" reading_order_no="32" segment_no="9" tag_type="text">who were receiving primary medical care treatment for</text>
<text top="474" left="55" width="234" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="9" tag_type="text">CFS were similar to people with CFS in the community.</text>
<text top="498" left="55" width="43" height="10" font="font5" id="p1_t37" reading_order_no="34" segment_no="12" tag_type="title">Methods</text>
<text top="510" left="55" width="114" height="9" font="font6" id="p1_t38" reading_order_no="35" segment_no="13" tag_type="title">Study Subjects and samples</text>
<text top="521" left="55" width="241" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="14" tag_type="text">Both studies adhered to human experimentation guide-</text>
<text top="533" left="55" width="241" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="14" tag_type="text">lines of the U.S. Department of Health and Human Serv-<b>Methods</b></text>
<text top="545" left="55" width="241" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="14" tag_type="text">ices and the Helsinki Declaration. The Centers for Disease<i><b>Study Subjects and samples</b></i></text>
<text top="557" left="55" width="241" height="9" font="font4" id="p1_t42" reading_order_no="39" segment_no="14" tag_type="text">Control and Prevention (CDC) Institutional Review</text>
<text top="568" left="55" width="241" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="14" tag_type="text">Board approved study protocols. All participants were vol-</text>
<text top="580" left="55" width="153" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="14" tag_type="text">unteers who gave informed consent.</text>
<text top="604" left="55" width="96" height="9" font="font7" id="p1_t45" reading_order_no="42" segment_no="15" tag_type="title">Physician surveillance study</text>
<text top="615" left="55" width="241" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="16" tag_type="text">Between 1988 and 1993, the CDC conducted a physician</text>
<text top="627" left="55" width="241" height="9" font="font4" id="p1_t47" reading_order_no="44" segment_no="16" tag_type="text">surveillance survey for CFS in primary care patients from</text>
<text top="639" left="55" width="241" height="9" font="font4" id="p1_t48" reading_order_no="45" segment_no="16" tag_type="text">Reno, Nevada, Wichita, Kansas, Grand Rapids, Michigan,<i>Physician surveillance study</i></text>
<text top="651" left="55" width="241" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="16" tag_type="text">and Atlanta, Georgia [7]. Patients were classified as CFS</text>
<text top="662" left="55" width="241" height="9" font="font4" id="p1_t50" reading_order_no="47" segment_no="16" tag_type="text">according to the 1988 case definition [11]. In 1992, we</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="16" tag_type="text">conducted a case control study of CFS patients and con-</text>
<text top="686" left="55" width="241" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="16" tag_type="text">trols in Atlanta by recruiting patients from physician sur-<a href="">orgia [7]. Patie</a>nts were classified as CFS</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="16" tag_type="text">veillance and sex, race, age matched non fatigued controls<a href="">tion [11]. In 1992, we</a></text>
<text top="709" left="55" width="241" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="16" tag_type="text">identified in the general Atlanta population [9,10]. The</text>
<text top="721" left="55" width="241" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="16" tag_type="text">case control study classified patients as CFS according to</text>
<text top="87" left="313" width="241" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="3" tag_type="text">the study collected information concerning several risk</text>
<text top="98" left="313" width="241" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="3" tag_type="text">factors and blood to measure associations between CFS<a href="">[9,10]</a>. The</text>
<text top="110" left="313" width="241" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="3" tag_type="text">and laboratory markers. The present study used remaining</text>
<text top="122" left="313" width="241" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="3" tag_type="text">archived serum samples from 22 CFS patients and 34 age</text>
<text top="134" left="313" width="241" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="3" tag_type="text">and sex matched controls. All CFS patients met criteria of</text>
<text top="145" left="313" width="181" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="3" tag_type="text">the current CFS research case definition [1]</text>
<text top="169" left="313" width="102" height="9" font="font7" id="p1_t62" reading_order_no="59" segment_no="4" tag_type="title">Population study participants</text>
<text top="181" left="313" width="241" height="9" font="font4" id="p1_t63" reading_order_no="60" segment_no="5" tag_type="text">Between 1997 and 2000, CDC conducted surveillance of</text>
<text top="192" left="313" width="241" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="5" tag_type="text">CFS in the general population of Wichita, Kansas [8].<a href="">nition [1</a>]</text>
<text top="204" left="313" width="241" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="5" tag_type="text">Briefly, the study involved random digit dial surveys to<i>Population study participants</i></text>
<text top="216" left="313" width="241" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="5" tag_type="text">identify people with CFS-like illness and clinically evalu-</text>
<text top="228" left="313" width="241" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="5" tag_type="text">ated and classified them according to criteria of the 1994<a href="">as [8</a>].</text>
<text top="239" left="313" width="241" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="5" tag_type="text">CFS research case definition [1]. Only 16% of those iden-</text>
<text top="251" left="313" width="241" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="5" tag_type="text">tified with CFS had been diagnosed or treated for CFS by</text>
<text top="263" left="313" width="241" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="5" tag_type="text">a physician [12]. The present study used archived serum</text>
<text top="275" left="313" width="241" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="5" tag_type="text">samples from 37 subjects with CFS and a 57 non-fatigued<a href="">nition [1]. Only 16%</a> of those iden-</text>
<text top="286" left="313" width="66" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="5" tag_type="text">control subjects</text>
<text top="310" left="313" width="51" height="9" font="font7" id="p1_t73" reading_order_no="70" segment_no="7" tag_type="title">Blood samples<a href=""> [12]. Th</a>e present study used archived serum</text>
<text top="322" left="313" width="241" height="9" font="font4" id="p1_t74" reading_order_no="71" segment_no="8" tag_type="text">Both the physician surveillance and population study col-</text>
<text top="333" left="313" width="241" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="8" tag_type="text">lected blood in BD Vacutainer Serum tubes. The samples</text>
<text top="345" left="313" width="241" height="9" font="font4" id="p1_t76" reading_order_no="73" segment_no="8" tag_type="text">were shipped by overnight courier to CDC where they<i>Blood samples</i></text>
<text top="357" left="313" width="241" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="8" tag_type="text">were dispensed into 0.5 ml aliquots and stored at -80°C</text>
<text top="369" left="313" width="53" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="8" tag_type="text">until testing.</text>
<text top="392" left="313" width="85" height="9" font="font6" id="p1_t79" reading_order_no="76" segment_no="10" tag_type="title">Reagents and Assays</text>
<text top="404" left="313" width="241" height="9" font="font4" id="p1_t80" reading_order_no="77" segment_no="11" tag_type="text">Commercially available kits were used for antibodies to</text>
<text top="416" left="313" width="241" height="9" font="font4" id="p1_t81" reading_order_no="78" segment_no="11" tag_type="text">ubiquitous nuclear and cellular autoantigens including</text>
<text top="427" left="313" width="241" height="9" font="font4" id="p1_t82" reading_order_no="79" segment_no="11" tag_type="text">dsDNA, ssDNA, Sm, U1-RNP, SS-A/Ro, SS-B/La, Scl-70,<i><b>Reagents and Assays</b></i></text>
<text top="439" left="313" width="241" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="11" tag_type="text">and Centromere. Immunoassays were purchased from</text>
<text top="451" left="313" width="241" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="11" tag_type="text">Helix Diagnostics (West Sacramento, CA) and reagents for</text>
<text top="463" left="313" width="241" height="9" font="font4" id="p1_t85" reading_order_no="82" segment_no="11" tag_type="text">western blots were purchased from Diagnostic Products</text>
<text top="474" left="313" width="241" height="9" font="font4" id="p1_t86" reading_order_no="83" segment_no="11" tag_type="text">Corporation (Los Angeles, CA). Purified Histone H3, and</text>
<text top="486" left="313" width="241" height="9" font="font4" id="p1_t87" reading_order_no="84" segment_no="11" tag_type="text">Histone H4 were purchased from Sigma (St. Louis, MO).</text>
<text top="498" left="313" width="241" height="9" font="font4" id="p1_t88" reading_order_no="85" segment_no="11" tag_type="text">and used in ELISA assays that were developed at Scripps.</text>
<text top="510" left="313" width="241" height="9" font="font4" id="p1_t89" reading_order_no="86" segment_no="11" tag_type="text">Conventional immunofluorescent antinuclear antibodies</text>
<text top="521" left="313" width="241" height="9" font="font4" id="p1_t90" reading_order_no="87" segment_no="11" tag_type="text">and rheumatoid factor tests were performed as described</text>
<text top="533" left="313" width="241" height="9" font="font4" id="p1_t91" reading_order_no="88" segment_no="11" tag_type="text">previously [13]. Preparations of microtubule-associated</text>
<text top="545" left="313" width="241" height="9" font="font4" id="p1_t92" reading_order_no="89" segment_no="11" tag_type="text">protein 2 (MAP2) and neurofilament triplet (NFT) pro-</text>
<text top="557" left="313" width="241" height="9" font="font4" id="p1_t93" reading_order_no="90" segment_no="11" tag_type="text">teins were purchased from Sigma (St. Louis, MO). The</text>
<text top="568" left="313" width="241" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="11" tag_type="text">commercially available ELISA assays were performed<a href="">ly [13]. </a>Preparations of microtubule-associated</text>
<text top="580" left="313" width="241" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="11" tag_type="text">according to the manufacturers instructions. The ELISA</text>
<text top="592" left="313" width="241" height="9" font="font4" id="p1_t96" reading_order_no="93" segment_no="11" tag_type="text">and western blot assays for the neuronal antigens were</text>
<text top="604" left="313" width="241" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="11" tag_type="text">developed at Scripps and were performed as previously</text>
<text top="615" left="313" width="63" height="9" font="font4" id="p1_t98" reading_order_no="95" segment_no="11" tag_type="text">described [14].</text>
<text top="639" left="313" width="77" height="9" font="font6" id="p1_t99" reading_order_no="96" segment_no="17" tag_type="title">Statistical Analysis</text>
<text top="651" left="313" width="241" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="18" tag_type="text">Because the subjects are derived from studies that are dis-</text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t101" reading_order_no="98" segment_no="18" tag_type="text">tinct in design and geographic location, each study was<a href="">d [14]</a>.</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="18" tag_type="text">analyzed separately. The distribution of autoantibodies<i><b>Statistical Analysis</b></i></text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t103" reading_order_no="100" segment_no="18" tag_type="text">between CFS and non-fatigued controls was compared by</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t104" reading_order_no="101" segment_no="18" tag_type="text">Fisher exact probability test. To derive an estimate of con-</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t105" reading_order_no="102" segment_no="18" tag_type="text">fidence, stratified groups were compared by the non-par-</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t106" reading_order_no="103" segment_no="18" tag_type="text">ametric chi square test. To determine associations,</text>
</page>
</pdf2xml>
